https://nl.marketscreener.com/koers/aandeel/GUARD-THERAPEUTICS-INTERN-39435558/nieuws/Guard-Therapeutics-International-AB-presenteert-positieve-klinische-gegevens-met-RMC-035-bij-patien-43278796/?utm_source=telegram&utm_medium=social&utm_campaign=share